Opportunistic infections are the major cause of mortality after nonmyeloablative unrelated bone marrow transplantation with alemtuzumab, fludarabine and melphalan
M.P. Carroll, D. BuchBarker, R. Schwartz, M.E. Agha, C. Tompkins, K. Baileys, K. O’Connell, A.D. Donnenberg, A.M. YeagerVolume:
11
Year:
2005
Language:
english
DOI:
10.1016/j.bbmt.2004.12.092
File:
PDF, 56 KB
english, 2005